Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Charity awards £1.5 million grant for glioma research
The researchers will trial the new treatment in Japan.

New treatment could be used to help both dogs and humans.

The Brain Tumour Charity has provided a “Quest for Cures” grant worth £1.5 million to support scientists working on a new immunotherapy drug for gliomas.

Led by Dr Jun Ishihara, from Imperial College London, the researchers are focusing on the protein interleukin 12 (IL-12), which is well-known for its anti-tumour effects and has long been studied as a possible cancer treatment.

Dr Ishihara’s team has added a collagen-binding site to IL-12. The researchers are also using novel nanotechnology to allow the treatment to cross the blood-brain barrier.

The UK researchers will work alongside vets at Nihon University in Japan to test the new treatment on dogs, offering it to owners as a possible treatment in cases where there are not usually other treatment options
available.

The adapted IL-12 treatment will also be tested in the laboratory on glioblastoma cells, to help the researchers determine which types of cell are likely to respond best.

As gliomas in dogs are similar to those in humans, it is hoped the research could pave the way for human clinical trials in the future.

Professor Daisuke Ito, veterinary neurology specialist at Nihon University, said: “From the veterinary aspect, the study of gliomas in dogs and research into new treatments brings hope to dog owners.

“Current treatment in dogs is very similar to that in humans: surgery, radiotherapy and chemotherapy. This is very expensive for owners and requires access to specialist veterinary hospitals. Any new treatments that are less expensive and easier to access will be welcomed by dog owners across the globe.
 
“I consistently saw 2-5 canine glioma cases each month, so this disease is an issue for canine health too, and we need to find a cure. If we can find one that works for both people and dogs, that would be a real breakthrough!”

 

Image (C) Shutterstock

Become a member or log in to add this story to your CPD history

Strangles survey seeks views of horse owners

News Story 1
 With Strangles Awareness Week just around the corner (5-11 May), vets are being encouraged to share a survey about the disease with their horse-owning clients.

The survey, which has been designed by Dechra, aims to raise awareness of Strangles and promote best practices to prevent its transmission. It includes questions about horse owners' experiences of strangles, together with preventative measures and vaccination.

Respondents to the survey will be entered into a prize draw to win two VIP tickets to Your Horse Live 2025. To access the survey, click here 

Click here for more...
News Shorts
Vivienne Mackinnon elected BVA Scottish Branch President

The British Veterinary Association (BVA) has elected Vivienne Mackinnon as its new BVA Scottish Branch president.

Dr Mackinnon has over 30 years of experience in veterinary care, encompassing both small animal and mixed practice. She has worked in practices in Scotland, England, New Zealand and Australia, before joining APHA to work in frontline disease control.

In her speech, Dr Mackinnon reflected on the changes in Scotland's veterinary industry and highlighted her commitment to veterinary education.

Dr Mackinnon said: "I look forward to working with colleagues across the veterinary professions to improve animal health and welfare in the country and support veterinary workplaces."